76 related articles for article (PubMed ID: 38584761)
21. Human bile microbiota: A retrospective study focusing on age and gender.
Serra N; Di Carlo P; D'Arpa F; Battaglia E; Fasciana T; Gulotta G; Maida CM; Rodolico V; Giammanco A; Sergi C
J Infect Public Health; 2021 Feb; 14(2):206-213. PubMed ID: 33486377
[TBL] [Abstract][Full Text] [Related]
22. Sphincter of Oddi laxity alters bile duct microbiota and contributes to the recurrence of choledocholithiasis.
Zhang Q; Ye M; Su W; Chen Y; Lou Y; Yang J; Ma T; Chen W; Gao S; Que R; Zhang B; Li H; Bai X; Liang T
Ann Transl Med; 2020 Nov; 8(21):1383. PubMed ID: 33313128
[TBL] [Abstract][Full Text] [Related]
23. Alterations of the Bile Microbiome in Recurrent Common Bile Duct Stone.
Ye C; Zhou W; Zhang H; Miao L; Lv G
Biomed Res Int; 2020; 2020():4637560. PubMed ID: 33062679
[TBL] [Abstract][Full Text] [Related]
24. Gallstone Disease and Microbiome.
Grigor'eva IN; Romanova TI
Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32498344
[TBL] [Abstract][Full Text] [Related]
25. PICRUSt2 for prediction of metagenome functions.
Douglas GM; Maffei VJ; Zaneveld JR; Yurgel SN; Brown JR; Taylor CM; Huttenhower C; Langille MGI
Nat Biotechnol; 2020 Jun; 38(6):685-688. PubMed ID: 32483366
[No Abstract] [Full Text] [Related]
26. Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data.
Chong J; Liu P; Zhou G; Xia J
Nat Protoc; 2020 Mar; 15(3):799-821. PubMed ID: 31942082
[TBL] [Abstract][Full Text] [Related]
27. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Dumonceau JM; Kapral C; Aabakken L; Papanikolaou IS; Tringali A; Vanbiervliet G; Beyna T; Dinis-Ribeiro M; Hritz I; Mariani A; Paspatis G; Radaelli F; Lakhtakia S; Veitch AM; van Hooft JE
Endoscopy; 2020 Feb; 52(2):127-149. PubMed ID: 31863440
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
Awolade P; Cele N; Kerru N; Gummidi L; Oluwakemi E; Singh P
Eur J Med Chem; 2020 Feb; 187():111921. PubMed ID: 31835168
[TBL] [Abstract][Full Text] [Related]
29. A Preliminary Study of Biliary Microbiota in Patients with Bile Duct Stones or Distal Cholangiocarcinoma.
Chen B; Fu SW; Lu L; Zhao H
Biomed Res Int; 2019; 2019():1092563. PubMed ID: 31662965
[TBL] [Abstract][Full Text] [Related]
30. The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile.
Molinero N; Ruiz L; Milani C; Gutiérrez-Díaz I; Sánchez B; Mangifesta M; Segura J; Cambero I; Campelo AB; García-Bernardo CM; Cabrera A; Rodríguez JI; González S; Rodríguez JM; Ventura M; Delgado S; Margolles A
Microbiome; 2019 Jul; 7(1):100. PubMed ID: 31272480
[TBL] [Abstract][Full Text] [Related]
31. Multiple recurrences after endoscopic removal of common bile duct stones: A retrospective analysis of 976 cases.
Kawaji Y; Isayama H; Nakai Y; Saito K; Sato T; Hakuta R; Saito T; Takahara N; Mizuno S; Kogure H; Matsubara S; Tada M; Kitano M; Koike K
J Gastroenterol Hepatol; 2019 Aug; 34(8):1460-1466. PubMed ID: 30761603
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Cholecystectomy on the Gut Microbiota: A Case-Control Study.
Yoon WJ; Kim HN; Park E; Ryu S; Chang Y; Shin H; Kim HL; Yi SY
J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30641967
[TBL] [Abstract][Full Text] [Related]
33. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.
Brennan CA; Garrett WS
Nat Rev Microbiol; 2019 Mar; 17(3):156-166. PubMed ID: 30546113
[TBL] [Abstract][Full Text] [Related]
34. Ursodeoxycholic acid after common bile duct stones removal for prevention of recurrence: A systematic review and meta-analysis of randomized controlled trials.
Chen X; Yan XR; Zhang LP
Medicine (Baltimore); 2018 Nov; 97(45):e13086. PubMed ID: 30407311
[TBL] [Abstract][Full Text] [Related]
35. 16S rRNA Gene Analysis with QIIME2.
Hall M; Beiko RG
Methods Mol Biol; 2018; 1849():113-129. PubMed ID: 30298251
[TBL] [Abstract][Full Text] [Related]
36. Metagenomics of pigmented and cholesterol gallstones: the putative role of bacteria.
Kose SH; Grice K; Orsi WD; Ballal M; Coolen MJL
Sci Rep; 2018 Jul; 8(1):11218. PubMed ID: 30046045
[TBL] [Abstract][Full Text] [Related]
37. Recurrent common bile duct stones as a late complication of endoscopic sphincterotomy.
Nzenza TC; Al-Habbal Y; Guerra GR; Manolas S; Yong T; McQuillan T
BMC Gastroenterol; 2018 Mar; 18(1):39. PubMed ID: 29544453
[TBL] [Abstract][Full Text] [Related]
38. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.
Gomi H; Solomkin JS; Schlossberg D; Okamoto K; Takada T; Strasberg SM; Ukai T; Endo I; Iwashita Y; Hibi T; Pitt HA; Matsunaga N; Takamori Y; Umezawa A; Asai K; Suzuki K; Han HS; Hwang TL; Mori Y; Yoon YS; Huang WS; Belli G; Dervenis C; Yokoe M; Kiriyama S; Itoi T; Jagannath P; Garden OJ; Miura F; de Santibañes E; Shikata S; Noguchi Y; Wada K; Honda G; Supe AN; Yoshida M; Mayumi T; Gouma DJ; Deziel DJ; Liau KH; Chen MF; Liu KH; Su CH; Chan ACW; Yoon DS; Choi IS; Jonas E; Chen XP; Fan ST; Ker CG; Giménez ME; Kitano S; Inomata M; Mukai S; Higuchi R; Hirata K; Inui K; Sumiyama Y; Yamamoto M
J Hepatobiliary Pancreat Sci; 2018 Jan; 25(1):3-16. PubMed ID: 29090866
[TBL] [Abstract][Full Text] [Related]
39. Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones.
Konstantakis C; Triantos C; Theopistos V; Theocharis G; Maroulis I; Diamantopoulou G; Thomopoulos K
World J Gastrointest Endosc; 2017 Jan; 9(1):26-33. PubMed ID: 28101305
[TBL] [Abstract][Full Text] [Related]
40. Advances of recurrent risk factors and management of choledocholithiasis.
Cai JS; Qiang S; Bao-Bing Y
Scand J Gastroenterol; 2017 Jan; 52(1):34-43. PubMed ID: 27610642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
